Eagle Asset Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-131,724
| Closed | -$3.75M | – | 589 |
|
|
2024
Q2 | $3.75M | Sell |
131,724
-559
| -0.4% | -$15.9K | 0.02% | 420 |
|
|
2024
Q1 | $3.86M | Sell |
132,283
-1,717
| -1% | -$50.1K | 0.02% | 419 |
|
|
2023
Q4 | $4.52M | Sell |
134,000
-2,393
| -2% | -$80.7K | 0.02% | 384 |
|
|
2023
Q3 | $4.18M | Buy |
136,393
+62,597
| +85% | +$1.92M | 0.02% | 377 |
|
|
2023
Q2 | $2.96M | Buy |
+73,796
| New | +$2.96M | 0.02% | 411 |
|
|
2015
Q2 | – | Sell |
-331,560
| Closed | -$29.5M | – | 665 |
|
|
2015
Q1 | $29.5M | Sell |
331,560
-6,522
| -2% | -$579K | 0.17% | 177 |
|
|
2014
Q4 | $30M | Buy |
338,082
+20,099
| +6% | +$1.78M | 0.17% | 180 |
|
|
2014
Q3 | $30.8M | Buy |
317,983
+17,881
| +6% | +$1.73M | 0.18% | 171 |
|
|
2014
Q2 | $27.6M | Buy |
300,102
+93,342
| +45% | +$8.57M | 0.15% | 194 |
|
|
2014
Q1 | $14.5M | Buy |
+206,760
| New | +$14.5M | 0.08% | 295 |
|
|
2013
Q4 | – | Sell |
-170,764
| Closed | -$8.11M | – | 647 |
|
|
2013
Q3 | $8.11M | Buy |
+170,764
| New | +$8.11M | 0.04% | 402 |
|